| Ytd | -40.21% | |
| 1y | -56.57% |
| Open | 11.76 | Prev Close | 11.57 | Low | 11.61 | High | 12.00 | Mkt Cap | 1.94B |
| Vol | 2.62M | Avg Vol | 1.81M | EPS | 0.71 | P/E | 16.82 | Forward P/E | 14.88 |
| Beta | 0.82 | Short Ratio | 4.58 | Inst. Own | 102.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 12.48 | 200-d Avg | 15.75 | 1yr Est | 18.00 |
VERX News
Vertex Pharmaceuticals could face competition in its most important market by far. The company is pr
Vertex (VERX) could produce exceptional returns because of its solid growth attributes.
Its sales rose at a double-digit rate; net profit growth was more modest. There's another developmen
Gainers Corvex (NASDAQ:MOVE) stock moved upwards by 44.6% to $15.56 during Tuesday's regular se
Vertex Inc (NASDAQ:VERX) reported upbeat earnings for the second quarter on Monday.
KING OF PRUSSIA, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ: VERX), the Decision-to-
Vertex Pharmaceuticals is executing a pivotal transition year, evolving from a CF-dominated biotech
Vertex, Inc. (VERX) Q2 2026 Earnings Call Transcript
Vertex NASDAQ: VERX reported second-quarter revenue at the high end of its guidance range and raised
Vertex Pharmaceuticals NASDAQ: VRTX reported second-quarter 2026 revenue growth of 12% year over yea
The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter en
Vertex (VERX) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estima
Vertex stock dipped late Monday on a mixed second-quarter report. But the biotech giant raised its s
Vertex Pharmaceuticals on Monday raised the upper end of its annual revenue forecast, banking on rob
KING OF PRUSSIA, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolida
Drawing on more than 2,100 enterprise leaders across two independent research firms, the findings re
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Announces Collaboration with Verte
VRTX heads into its Q2 earnings release with Trikafta, Alyftrek, Casgevy and Journavx in focus as in
Morgan Stanley analyst Chris Quintero downgrades Vertex (NASDAQ:VERX) from Overweight to Equal-We
Vertex Pharmaceuticals' latest acquisition grants it access to products with $5 billion peak annual
KING OF PRUSSIA, Pa., July 14, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading provid
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
On Wednesday, 807 companies reached new 52-week lows.